Jiangsu Eastern Shenghong stock
000301.SZSHZJiangsu Eastern Shenghong Co., Ltd., Basic MaterialsISIN CNE0000012K6
47Score 47 out of 100, Weak
Price and trend
36 / 100
Price history
+0.2% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 19% below it.
Since August 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Sharply down: the price has fallen very quickly lately (RSI 16).
The price is 32% below its 52-week high. Largest decline in 20 years: 85% (September 2007 to July 2013).
Chart figures for advanced users
- SMA 50$1.89
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$1.84
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)16
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.37
- The lowest closing price of the last twelve months.
- Resistance$2.21
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Jiangsu Eastern Shenghong Co., Ltd. belongs to the Chemicals industry (China) and, with a market value of $9.87B, is number 15 of 44 companies in its industry on MEQIRI.
- MEQIRI Score 47 out of 100 (Weak): rank 343 of 461 in Basic Materials, median 57.
- The P/E is 14.2 (Chemicals median 19.2, own median of recent years 32.5).
Show more
- Our model puts fair value at $1.35, with the price 11% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow 306% of earnings over the last 12 months.Fundamentals 62
- Growing faster than its industryRevenue up 28.3% a year since 2020, Chemicals median 14.2%.Growth 88
- Modestly valuedP/E 14.2, Chemicals median 19.2, own median 32.5.Valuation 71
Weaknesses
- DilutionShare count up 37% since 2020.Capital allocation 17
- High debtDebt 3.4 times equity (latest quarter), Chemicals median 0.45.Stability 19
- Earnings per share fallingDown 33.9% a year since 2020.
Its standout strengths are growth and valuation, while stability and capital allocation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $0.96 and expensive above $2.24 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $0.67 (cash-flow model) and $2.03 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $1.30, at 7.8% it would be $1.41.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (19.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 3.9% on the twelve months before. Revenue has grown strongly since 2006, at around 21% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 4%, operating 3%, net 0%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 26 Apr 2027in 164 days
- Last reported
- 27 Oct 2026EPS reported $0.00 (expected $0.02)below expectations
Analyst estimates
- Earnings per share
- $0.13−19.0%
- Revenue
- $21.36B−3.6%
- Earnings per share
- $0.13−12.7%
- Revenue
- $22.89B−2.3%
MEQIRI has stored the estimates since 24 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Jiangsu Eastern Shenghong
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 47
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Zhejiang Juhua600160.SS $12.86B62
- LG Chem051910.KS $12.78B39
- Formosa Chemicals & Fibre1326.TW $12.68B52
- Ganfeng Lithium002460.SZ $11.5B51
- Mitsubishi Chemical Group4188.T $9.2B55
- SasolSSL $9.19B59
- Syensqo SA/NVSYENS.BR $8.98B54
- Shandong Hualu-Hengsheng Chemical600426.SS $7.62B61
ETFs that hold Jiangsu Eastern Shenghong
Held by 34 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi MSCI China A UCITS ETF AccCNAA | 0.17% | 0.35% | €84.92M |
| Xtrackers Harvest CSI300 UCITS ETF 1DRQFI | 0.13% | 0.65% | €251.68M |
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.11% | 0.65% | €10.81M |
Show 5 more
| UBS MSCI China Universal UCITS ETF USD disUETC | 0.03% | 0.30% | €132.6M |
| Franklin FTSE China UCITS ETFFLXC | 0.02% | 0.19% | €1.43B |
| Xtrackers MSCI China UCITS ETF 1CXCS6 | 0.02% | 0.65% | €1.51B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.01% | 0.17% | €5.24B |
| Amundi MSCI EM Asia ESG Broad Transition UCITS ETF AccLCUA | 0.01% | 0.25% | €661.06M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 21 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.